Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A

BACKGROUND: With the introduction of cyclosporine A (CsA), long-term allograft function has significantly improved. Problems related to limited therapeutic margins and CsA toxicity remain unsolved. Until now there have been no reliable, practical markers to measure the biologic activity of CsA in vi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Giese, Thomas (VerfasserIn) , Zeier, Martin (VerfasserIn) , Schemmer, Peter (VerfasserIn) , Uhl, Waldemar (VerfasserIn) , Schöls, Margarita (VerfasserIn) , Dengler, Thomas (VerfasserIn) , Büchler, Markus W. (VerfasserIn) , Meuer, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2004
In: Transplantation
Year: 2004, Jahrgang: 77, Heft: 3, Pages: 339-344
ISSN:1534-6080
DOI:10.1097/01.TP.0000109260.00094.01
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://dx.doi.org/10.1097/01.TP.0000109260.00094.01
Volltext
Verfasserangaben:Thomas Giese, Martin Zeier, Peter Schemmer, Waldemar Uhl, Margarita Schoels, Thomas Dengler, Markus Buechler, and Stefan Meuer

MARC

LEADER 00000caa a2200000 c 4500
001 1760546771
003 DE-627
005 20230428014430.0
007 cr uuu---uuuuu
008 210616s2004 xx |||||o 00| ||eng c
024 7 |a 10.1097/01.TP.0000109260.00094.01  |2 doi 
035 |a (DE-627)1760546771 
035 |a (DE-599)KXP1760546771 
035 |a (OCoLC)1341416416 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Giese, Thomas  |d 1962-  |e VerfasserIn  |0 (DE-588)143133543  |0 (DE-627)704399075  |0 (DE-576)333724496  |4 aut 
245 1 0 |a Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients  |b a novel perspective toward individually optimized drug doses of cyclosporine A  |c Thomas Giese, Martin Zeier, Peter Schemmer, Waldemar Uhl, Margarita Schoels, Thomas Dengler, Markus Buechler, and Stefan Meuer 
264 1 |c 2004 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.06.2021 
520 |a BACKGROUND: With the introduction of cyclosporine A (CsA), long-term allograft function has significantly improved. Problems related to limited therapeutic margins and CsA toxicity remain unsolved. Until now there have been no reliable, practical markers to measure the biologic activity of CsA in vivo. METHODS: Expression of NFAT (nuclear factor of activated T cells)-regulated genes (interleukin 2, interferon-gamma, and granulocyte-macrophage colony-stimulating factor) in phorbol myristate acetate/ionomycin-stimulated peripheral blood from healthy volunteers (n=34) and from stable renal (n=25), cardiac (n=26), and liver (n=14) transplant recipients receiving CsA therapy was measured by quantitative real-time reverse transcriptase-polymerase chain reaction before and 2 hr after drug intake. Gene expression and CsA plasma levels were correlated. RESULTS: Two hours after oral CsA ingestion, the mean suppression of induced interleukin 2, interferon-gamma, and granulocyte-macrophage colony-stimulating factor gene expression was 85%. The individual decline of NFAT-regulated gene expression and the total drug exposure at this time point were closely related. Six hours after oral CsA uptake, gene expression levels reached predose values and subsequently increased further in some patients (rebound effect). CONCLUSION: Quantitative measurement of the inhibition of NFAT-regulated gene expression 2 hr after CsA intake represents a novel approach to assess the biologic effectiveness of CsA therapy and has the potential to enable individualized immunosuppressive regimens. 
650 4 |a Adult 
650 4 |a Aged 
650 4 |a Case-Control Studies 
650 4 |a Cyclosporine 
650 4 |a DNA-Binding Proteins 
650 4 |a Dose-Response Relationship, Drug 
650 4 |a Female 
650 4 |a Gene Expression 
650 4 |a Granulocyte-Macrophage Colony-Stimulating Factor 
650 4 |a Heart Transplantation 
650 4 |a Humans 
650 4 |a Immunosuppressive Agents 
650 4 |a Interferon-gamma 
650 4 |a Interleukin-2 
650 4 |a Kidney Transplantation 
650 4 |a Liver Transplantation 
650 4 |a Male 
650 4 |a Middle Aged 
650 4 |a NFATC Transcription Factors 
650 4 |a Nuclear Proteins 
650 4 |a Organ Transplantation 
650 4 |a Population Surveillance 
650 4 |a RNA, Messenger 
650 4 |a Transcription Factors 
700 1 |a Zeier, Martin  |e VerfasserIn  |0 (DE-588)1026480302  |0 (DE-627)726772356  |0 (DE-576)371826438  |4 aut 
700 1 |a Schemmer, Peter  |d 1967-  |e VerfasserIn  |0 (DE-588)1022604244  |0 (DE-627)717006794  |0 (DE-576)365668230  |4 aut 
700 1 |a Uhl, Waldemar  |d 1960-  |e VerfasserIn  |0 (DE-588)172996058  |0 (DE-627)69792159X  |0 (DE-576)133849317  |4 aut 
700 1 |a Schöls, Margarita  |e VerfasserIn  |0 (DE-588)1153925567  |0 (DE-627)1015526624  |0 (DE-576)500645663  |4 aut 
700 1 |a Dengler, Thomas  |e VerfasserIn  |0 (DE-588)1077763050  |0 (DE-627)837469198  |0 (DE-576)184645417  |4 aut 
700 1 |a Büchler, Markus W.  |d 1955-  |e VerfasserIn  |0 (DE-588)120893339  |0 (DE-627)080952526  |0 (DE-576)292434146  |4 aut 
700 1 |a Meuer, Stefan  |d 1951-  |e VerfasserIn  |0 (DE-588)1020440198  |0 (DE-627)691221286  |0 (DE-576)360422454  |4 aut 
773 0 8 |i Enthalten in  |t Transplantation  |d Hagerstown, Md. : Lippincott Williams & Wilkins, 1963  |g 77(2004), 3, Seite 339-344  |h Online-Ressource  |w (DE-627)32529738X  |w (DE-600)2035395-9  |w (DE-576)097188794  |x 1534-6080  |7 nnas  |a Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients a novel perspective toward individually optimized drug doses of cyclosporine A 
773 1 8 |g volume:77  |g year:2004  |g number:3  |g pages:339-344  |g extent:6  |a Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients a novel perspective toward individually optimized drug doses of cyclosporine A 
856 4 0 |u https://dx.doi.org/10.1097/01.TP.0000109260.00094.01  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210616 
993 |a Article 
994 |a 2004 
998 |g 1020440198  |a Meuer, Stefan  |m 1020440198:Meuer, Stefan  |d 910000  |d 911600  |e 910000PM1020440198  |e 911600PM1020440198  |k 0/910000/  |k 1/910000/911600/  |p 8  |y j 
998 |g 120893339  |a Büchler, Markus W.  |m 120893339:Büchler, Markus W.  |d 910000  |d 910200  |e 910000PB120893339  |e 910200PB120893339  |k 0/910000/  |k 1/910000/910200/  |p 7 
998 |g 1077763050  |a Dengler, Thomas  |m 1077763050:Dengler, Thomas  |d 910000  |d 910100  |e 910000PD1077763050  |e 910100PD1077763050  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1153925567  |a Schöls, Margarita  |m 1153925567:Schöls, Margarita  |d 910000  |d 911600  |e 910000PS1153925567  |e 911600PS1153925567  |k 0/910000/  |k 1/910000/911600/  |p 5 
998 |g 172996058  |a Uhl, Waldemar  |m 172996058:Uhl, Waldemar  |p 4 
998 |g 1022604244  |a Schemmer, Peter  |m 1022604244:Schemmer, Peter  |d 910000  |d 910200  |e 910000PS1022604244  |e 910200PS1022604244  |k 0/910000/  |k 1/910000/910200/  |p 3 
998 |g 1026480302  |a Zeier, Martin  |m 1026480302:Zeier, Martin  |d 910000  |d 910100  |e 910000PZ1026480302  |e 910100PZ1026480302  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 143133543  |a Giese, Thomas  |m 143133543:Giese, Thomas  |d 910000  |d 911600  |e 910000PG143133543  |e 911600PG143133543  |k 0/910000/  |k 1/910000/911600/  |p 1  |x j 
999 |a KXP-PPN1760546771  |e 3938711264 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 16.06.2021"],"recId":"1760546771","type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"a novel perspective toward individually optimized drug doses of cyclosporine A","title_sort":"Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients","title":"Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients"}],"person":[{"family":"Giese","given":"Thomas","roleDisplay":"VerfasserIn","role":"aut","display":"Giese, Thomas"},{"display":"Zeier, Martin","role":"aut","roleDisplay":"VerfasserIn","given":"Martin","family":"Zeier"},{"family":"Schemmer","given":"Peter","roleDisplay":"VerfasserIn","role":"aut","display":"Schemmer, Peter"},{"family":"Uhl","role":"aut","roleDisplay":"VerfasserIn","given":"Waldemar","display":"Uhl, Waldemar"},{"display":"Schöls, Margarita","roleDisplay":"VerfasserIn","role":"aut","given":"Margarita","family":"Schöls"},{"family":"Dengler","given":"Thomas","role":"aut","roleDisplay":"VerfasserIn","display":"Dengler, Thomas"},{"family":"Büchler","given":"Markus W.","role":"aut","roleDisplay":"VerfasserIn","display":"Büchler, Markus W."},{"family":"Meuer","given":"Stefan","role":"aut","roleDisplay":"VerfasserIn","display":"Meuer, Stefan"}],"language":["eng"],"id":{"eki":["1760546771"],"doi":["10.1097/01.TP.0000109260.00094.01"]},"name":{"displayForm":["Thomas Giese, Martin Zeier, Peter Schemmer, Waldemar Uhl, Margarita Schoels, Thomas Dengler, Markus Buechler, and Stefan Meuer"]},"physDesc":[{"extent":"6 S."}],"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"2004"}],"relHost":[{"note":["Gesehen am 11.06.2019"],"part":{"pages":"339-344","year":"2004","extent":"6","text":"77(2004), 3, Seite 339-344","issue":"3","volume":"77"},"recId":"32529738X","pubHistory":["1.1963 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1534-6080"],"eki":["32529738X"],"zdb":["2035395-9"]},"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"Transplantation Society"}],"title":[{"subtitle":"the official journal of the Transplantation Society","title_sort":"Transplantation","title":"Transplantation"}],"origin":[{"publisher":"Lippincott Williams & Wilkins ; Ovid","dateIssuedDisp":"1963-","dateIssuedKey":"1963","publisherPlace":"Hagerstown, Md. ; [Erscheinungsort nicht ermittelbar]"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"disp":"Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients a novel perspective toward individually optimized drug doses of cyclosporine ATransplantation"}]} 
SRT |a GIESETHOMAMONITORING2004